SCHEMBL30839788

SCHEMBL30839788

Fc1cccc(N2CCNCC2)c1Cl

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 4/20 0.69
DRD2 P14416 2/20 0.69
DRD3 P35462 2/20 0.69
HTR1A P08908 8/20 0.59
HTR2A P28223 2/20 0.59
DRD4 P21917 1/20 0.59
HTR2C P28335 1/20 0.59
SLC6A2 P23975 4/20 0.52
HTR3A P46098 3/20 0.50
HTR7 P34969 3/20 0.50
HTR6 P50406 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
HTR3E A5X5Y0 1/20 0.50
HTR3B O95264 1/20 0.50
NCF1 P14598 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5365109 1.00 ADRB1 (0.69) ADRB1DRD2DRD3HTR1AHTR2A
Hydrochloric Acid SCHEMBL29176265 0.98 ADRB1 (0.67) ADRB1DRD2DRD3HTR1AHTR2A
SCHEMBL3095707 0.84 ADRB1 (0.56) ADRB1DRD2DRD3HTR1AHTR2A
Hydrochloric Acid SCHEMBL5383409 0.82 ADRB1 (0.54) ADRB1DRD2DRD3HTR1AHTR2A
SCHEMBL8511 0.81 DRD2 (1.00) ADRB1DRD2DRD3HTR1AHTR2A
SCHEMBL6352699 0.81 DRD2 (1.00) ADRB1DRD2DRD3HTR1AHTR2A
SCHEMBL1441614 0.81 HTR1A (0.58) ADRB1DRD2DRD3HTR1AHTR2A
SCHEMBL30839785 0.81 HTR1A (0.58) ADRB1DRD2DRD3HTR1AHTR2A
SCHEMBL29367982 0.81 DRD2 (1.00) ADRB1DRD2DRD3HTR1AHTR2A
SCHEMBL2414711 0.81 ADRB1 (0.62) ADRB1DRD2DRD3HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117769545-A Tri-fused ring derivative-containing regulator, preparation method and application thereof 上海枢境生物科技有限公司 2024-03-26 CN disclosed